RNS Number : 7641B
OptiBiotix Health PLC
05 February 2024

OptiBiotix Health plc

("OptiBiotix" or the "Company")


Presentation at ProBiota 2024


OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces it will be presenting research and meeting potential partners at ProBiota 2024 between 7-9 February 2024, in Milan.


ProBiota is the leading annual event for the global prebiotic, probiotic and the microbiome focused food and pharma industries. The conference is world renowned for scientists and industry leaders who are seeking to translate the latest science into new products in the supplements and ingredients market.


The Company will be presenting on novel methods to design a range of prebiotic approaches which stimulate the growth of probiotics of commercial interest. These can be used as excipients in probiotic capsules, tablets, and sachets to selectively support the growth of the probiotic and enhance its health benefit.  These synbiotics represent an area of growing market interest as a means to bring innovation and differentiation into the probiotic market with a forecast CAGR of 8.2% between 2022 and 2027 Synbiotic Products Market Size & Share Analysis - Industry Research Report - Growth Trends (mordorintelligence.com)


Commenting, Stephen O'Hara, CEO of OptiBiotix said: "We were pleased to be presenting our research on synbiotics at ProBiota. Attending conferences like ProBiota, which attract scientists from around the world, allow us to present our work to industry and increases awareness of OptiBiotix and its products. This often attracts commercial interest in our technology and helps build the product pipeline in different territories and with different partners. This increases the scale of the opportunity, and the potential value of OptiBiotix." 


For further information, please contact:

OptiBiotix Health plc


Neil Davidson, Chairman

Contact via Walbrook below

Stephen O'Hara, Chief Executive


Peterhouse Capital Limited (Broker)

Tel: 020 7220 9797

Duncan Vasey / Lucy Williams

Walbrook PR Ltd

Mob: 07876 741 001

Anna Dunphy


About OptiBiotix - www.optibiotix.com

OptiBiotix Health plc (AIM: OPTI) brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.


OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.


OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes. 


This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Grafico Azioni Optibiotix Health (LSE:OPTI)
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Optibiotix Health
Grafico Azioni Optibiotix Health (LSE:OPTI)
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Optibiotix Health